Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)-Reference-Cited by-同舟云学术

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

Published:2019-09-20 Issue:9 Volume:16 Page:e1002895
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Waitt Catriona^ORCID,Orrell Catherine,Walimbwa Stephen,Singh Yashna,Kintu Kenneth,Simmons Bryony,Kaboggoza Julian^ORCID,Sihlangu Mary,Coombs Julie-Anne^ORCID,Malaba Thoko,Byamugisha Josaphat^ORCID,Amara Alieu,Gini Joshua,Else Laura,Heiburg Christie,Hodel Eva Maria^ORCID,Reynolds Helen^ORCID,Mehta Ushma^ORCID,Byakika-Kibwika Pauline^ORCID,Hill Andrew,Myer Landon^ORCID,Lamorde Mohammed,Khoo Saye^ORCID

Funder

ViiV Healthcare

Wellcome Trust

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference23 articles.

1. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa;L Myer;J Int AIDS Soc,2015

2. Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China;K Meyers;PLoS One,2015

3. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection;SL Walmsley;N Engl J Med,2013

4. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults;S Min;AIDS,2011

5. Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy;G Meintjes;S Afr Med J,2015

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study;BMC Infectious Diseases;2024-09-02

2. Advances in HIV Management During Pregnancy and Infant Feeding;Infectious Disease Clinics of North America;2024-09

3. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

4. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol;PLOS ONE;2024-08-19

5. Pharmacokinetics of drugs used to treat drug sensitive-tuberculosis in breastfeeding mother-infant pairs: An observational pharmacokinetic study;Wellcome Open Research;2024-08-12